Amlexanox

FDA Approved: * September 29, 2004
Pharm Company: * ULURU
Category: Ulcer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Amlexanox Overview

Amlexanox (trade name Aphthasol) is an anti-inflammatory antiallergic immunomodulator used to treat recurrent aphthous ulcers (canker sores), and (in Japan) several inflammatory conditions. This drug has been discontinued in the U.S.[1] Contents 1 Medical uses 2 Contraindications 3 Adverse effects 4 Mechanism of action 5 Chemistry 6 Pharmacokinetics 7 History 8 Society and culture 8.1 Economics 9 Research 10 Synthesis 11 References Medical uses Amlexanox is the activ...

Read more Amlexanox Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Amlexanox

Recent Amlexanox Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Other drugs which contain Amlexanox or a similar ingredient: (2 results)

• APHTHASOL Amlexanox
• ORADISC A Amlexanox1 discussion